Ionis Pharmaceuticals, Inc. Debt Securities, Available-for-sale, Current
Ionis Pharmaceuticals, Inc. (IONS) had Debt Securities, Available-for-sale, Current of $1.14 billion as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2026-07-29
- 2026-06-30: Debt Securities, Available-for-sale, Current $1.14B.
- 2026-03-31: Debt Securities, Available-for-sale, Current $1.12B.
- 2025-12-31: Debt Securities, Available-for-sale, Current $1.58B.
- 2025-09-30: Debt Securities, Available-for-sale, Current $1.28B.
| Period end | Debt Securities, Available-for-sale, Current | Debt Securities, Available-for-sale, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.14B 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $1.12B 10-Q · filed 2026-04-29 | |
| 2025-12-31 | $1.58B 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $1.28B 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $1.33B 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $1.23B 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $1.40B 10-K · filed 2026-02-26 | |
| 2024-09-30 | $1.49B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $1.34B 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $1.30B 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.31B 10-K · filed 2025-02-19 | |
| 2023-09-30 | $1.34B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.54B 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.47B 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $1.21B 10-K · filed 2024-02-21 | |
| 2022-09-30 | $1.12B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.03B 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.51B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $613.00M 10-K · filed 2023-02-22 | $1.25B 10-K · filed 2022-02-25 |
| 2021-09-30 | $1.35B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $1.49B 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $1.41B 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $1.49B 10-K · filed 2022-02-25 | |
| 2020-09-30 | $1.70B 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $1.82B 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $1.90B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $1.82B 10-K · filed 2021-02-24 | |
| 2019-09-30 | $1.97B 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $1.99B 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.88B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $1.81B 10-K · filed 2020-03-02 | |
| 2018-09-30 | $1.48B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.17B 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $807.80M 10-Q · filed 2018-05-07 | |
| 2017-12-31 | $893.09M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $851.62M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $722.72M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $746.06M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $580.54M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $603.57M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $551.56M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $610.47M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $650.39M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $685.60M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $635.45M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $546.71M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $585.83M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $518.77M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $496.75M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $469.51M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $496.79M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $414.49M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $294.21M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $264.26M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $249.96M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $259.01M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $250.38M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $277.55M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $278.19M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $309.50M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $310.16M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $402.30M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |